BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1442931)

  • 1. Mutations of the Ki-ras oncogene in endometrial carcinoma.
    Ignar-Trowbridge D; Risinger JI; Dent GA; Kohler M; Berchuck A; McLachlan JA; Boyd J
    Am J Obstet Gynecol; 1992 Jul; 167(1):227-32. PubMed ID: 1442931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma.
    Duggan BD; Felix JC; Muderspach LI; Tsao JL; Shibata DK
    Cancer Res; 1994 Mar; 54(6):1604-7. PubMed ID: 8137266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ras gene mutations in human endometrial carcinoma.
    Varras MN; Koffa M; Koumantakis E; Ergazaki M; Protopapa E; Michalas S; Spandidos DA
    Oncology; 1996; 53(6):505-10. PubMed ID: 8960147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
    Caduff RF; Johnston CM; Frank TS
    Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras gene mutation and amplification in human nonmelanoma skin cancers.
    Pierceall WE; Goldberg LH; Tainsky MA; Mukhopadhyay T; Ananthaswamy HN
    Mol Carcinog; 1991; 4(3):196-202. PubMed ID: 2064725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on ras oncogene activation in endometrial carcinoma.
    Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
    Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of ras gene mutations in gastrointestinal cancers.
    Shen C; Chang JG; Lee LS; Yang MJ; Chen TC; Lin KY; Lee MD; Chen PH
    J Formos Med Assoc; 1991 Dec; 90(12):1149-54. PubMed ID: 1686883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.
    Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
    Gynecol Oncol; 1996 Nov; 63(2):238-46. PubMed ID: 8910634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
    Xu KM
    Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing.
    Grimmond SM; Raghavan D; Russell PJ
    Urol Res; 1992; 20(2):121-6. PubMed ID: 1553789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.
    Sasaki H; Nishii H; Takahashi H; Tada A; Furusato M; Terashima Y; Siegal GP; Parker SL; Kohler MF; Berchuck A
    Cancer Res; 1993 Apr; 53(8):1906-10. PubMed ID: 8467512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
    Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
    Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
    Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
    Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Point mutation of ras oncogene in endometrial carcinoma].
    Fujimoto I; Hasumi K
    Rinsho Byori; 1993 Jun; Suppl 94():29-37. PubMed ID: 8103124
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris].
    Liu XF
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence of Ki-ras codon 12 mutations in melanocytic lesions.
    Albino AP; Nanus DM; Davis ML; McNutt NS
    J Cutan Pathol; 1991 Aug; 18(4):273-8. PubMed ID: 1939786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.